-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
- X4 Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.43M, a 13.4% increase year-over-year.
- X4 Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.07M, a 51% increase year-over-year.
- X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2023 was $8.69M, a 67.1% increase from 2022.
- X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2022 was $5.2M, a 15.9% decline from 2021.
- X4 Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2021 was $6.18M, a 13.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)